CH593254A5 - - Google Patents

Info

Publication number
CH593254A5
CH593254A5 CH1020673A CH1020673A CH593254A5 CH 593254 A5 CH593254 A5 CH 593254A5 CH 1020673 A CH1020673 A CH 1020673A CH 1020673 A CH1020673 A CH 1020673A CH 593254 A5 CH593254 A5 CH 593254A5
Authority
CH
Switzerland
Application number
CH1020673A
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to CH706276A priority Critical patent/CH593932A5/fr
Priority to CH706076A priority patent/CH593963A5/xx
Priority to CH706176A priority patent/CH593991A5/xx
Publication of CH593254A5 publication Critical patent/CH593254A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids
    • C07F9/4059Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B63SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
    • B63BSHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING 
    • B63B2211/00Applications
    • B63B2211/02Oceanography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
CH1020673A 1972-07-13 1973-07-12 CH593254A5 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CH706276A CH593932A5 (en) 1972-07-13 1973-07-12 (15)-(Hetero) aryl prostaglandin analogues - with long-lasting prostaglandin-like activity
CH706076A CH593963A5 (es) 1972-07-13 1973-07-12
CH706176A CH593991A5 (es) 1972-07-13 1973-07-12

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27122072A 1972-07-13 1972-07-13

Publications (1)

Publication Number Publication Date
CH593254A5 true CH593254A5 (es) 1977-11-30

Family

ID=23034697

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1020673A CH593254A5 (es) 1972-07-13 1973-07-12

Country Status (25)

Country Link
JP (4) JPS5241257B2 (es)
AR (2) AR209064A1 (es)
AT (1) AT367033B (es)
BE (1) BE802231A (es)
CA (1) CA1041495A (es)
CH (1) CH593254A5 (es)
CS (1) CS201027B2 (es)
DD (2) DD116459A5 (es)
DE (1) DE2334945A1 (es)
ES (4) ES416865A1 (es)
FI (1) FI57583C (es)
FR (1) FR2192834B1 (es)
GB (1) GB1446341A (es)
HU (4) HU172058B (es)
IE (1) IE37909B1 (es)
IL (2) IL42691A (es)
IN (1) IN138789B (es)
LU (1) LU68015A1 (es)
NL (1) NL7309792A (es)
NO (2) NO143741C (es)
PH (1) PH11461A (es)
SE (3) SE7705946L (es)
SU (4) SU644384A3 (es)
YU (1) YU187773A (es)
ZA (1) ZA734769B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
DE2416193C2 (de) 1974-04-03 1985-08-14 Hoechst Ag, 6230 Frankfurt Prostaglandin-Analoge, Verfahren zu ihrer Herstellung sowie ihre Verwendung als cytoprotektives Mittel
DE2463432C2 (es) * 1974-04-03 1987-06-19 Hoechst Ag, 6230 Frankfurt, De
ZA747723B (en) * 1974-12-11 1976-11-24 Pfizer 11-desoxy-15-substituted-omega-pentanor prostaglandins
US4149006A (en) * 1977-01-24 1979-04-10 G. D. Searle & Co. Prostaglandin derivatives having alkynyl, hydroxy and aryloxy junctions in the 2β side chain
GB8329559D0 (en) * 1983-11-04 1983-12-07 Erba Farmitalia Furyl derivatives of 16-substituted prostaglandins preparations
SE9002596D0 (sv) * 1990-08-08 1990-08-08 Pharmacia Ab A method for synthesis of prostaglandin derivatives
US6602900B2 (en) 1992-09-21 2003-08-05 Allergan, Inc. Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5972991A (en) * 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
KR100578616B1 (ko) * 2004-07-23 2006-05-10 한미약품 주식회사 D-에리트로-2,2-다이플루오로-2-데옥시-1-옥소라이보스화합물의 제조방법
RU2730520C2 (ru) * 2013-12-13 2020-08-24 Аллерган, Инк. Твердые формы альфа, омега дизамещенного дигидроксициклопентильного соединения и способы их получения и применения

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1324737A (en) * 1970-11-02 1973-07-25 Upjohn Co Prostaglandins and the preparation thereof
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
IL42373A (en) * 1972-06-02 1977-08-31 Pfizer Oxaprostagliandins and their preparation

Also Published As

Publication number Publication date
NO743492L (no) 1974-01-15
SE7705947L (sv) 1977-05-20
SU584791A3 (ru) 1977-12-15
FI57583C (fi) 1980-09-10
AR214383A1 (es) 1979-06-15
ES437038A1 (es) 1977-01-01
FR2192834B1 (es) 1979-04-06
ZA734769B (en) 1974-06-26
ES437039A1 (es) 1977-01-01
ES416865A1 (es) 1976-03-01
FR2192834A1 (es) 1974-02-15
JPS5297958A (en) 1977-08-17
DD109210A5 (es) 1974-10-20
SU645563A3 (ru) 1979-01-30
JPS5241257B2 (es) 1977-10-17
IE37909L (en) 1974-01-13
IL42691A (en) 1979-07-25
AR209064A1 (es) 1977-03-31
HU171158B (hu) 1977-11-28
ES437037A1 (es) 1977-01-01
IL50308A0 (en) 1976-10-31
IN138789B (es) 1976-04-03
IL42691A0 (en) 1973-10-25
FI57583B (fi) 1980-05-30
HU171156B (hu) 1977-11-28
SU645564A3 (ru) 1979-01-30
NO143741B (no) 1980-12-29
SU644384A3 (ru) 1979-01-25
IE37909B1 (en) 1977-11-09
AU5778473A (en) 1975-01-09
NO143741C (no) 1981-04-08
NL7309792A (es) 1974-01-15
JPS4992053A (es) 1974-09-03
DD116459A5 (es) 1975-11-20
ATA620773A (de) 1981-10-15
SE7705945L (sv) 1977-05-20
YU187773A (en) 1982-02-25
PH11461A (en) 1978-02-01
JPS52122349A (en) 1977-10-14
CS201027B2 (en) 1980-10-31
DE2334945A1 (de) 1974-03-07
GB1446341A (en) 1976-08-18
NO144830C (no) 1981-11-18
BE802231A (fr) 1974-01-14
HU171946B (hu) 1978-04-28
AT367033B (de) 1982-05-25
LU68015A1 (es) 1974-01-21
SE7705946L (sv) 1977-05-20
CA1041495A (en) 1978-10-31
NO144830B (no) 1981-08-10
JPS5293753A (en) 1977-08-06
HU172058B (hu) 1978-05-28

Similar Documents

Publication Publication Date Title
JPS4897473A (es)
FR2211757A1 (es)
AU472383B2 (es)
FR2192834B1 (es)
FR2194398A1 (es)
JPS4884549A (es)
FR2168343A1 (es)
JPS4899805A (es)
JPS4899649U (es)
JPS5729293Y2 (es)
JPS5311201B2 (es)
FR2193210A1 (es)
JPS4875297A (es)
JPS4940591U (es)
JPS4884805U (es)
JPS4997181U (es)
JPS4876307A (es)
CH591865A5 (es)
NL7303305A (es)
CH585713A5 (es)
BG18025A1 (es)
DD105972A3 (es)
CH596753A5 (es)
CH594630A5 (es)
CH594562A5 (es)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased